Affitope AD01

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAffitope AD01

Drug Alias NameAD 01 - AFFiRiSAlzheimer AD01AD-1

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulantsBeta amyloid A4 protein inhibitors

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAffiris Ag

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAffiris Ag

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A